News
-
-
PRESS RELEASE
Original-Research: SYNBIOTIC SE (von NuWays AG): BUY
NuWays AG releases research on SYNBIOTIC SE, recommending BUY at a target price of EUR 5.50. Recent strategic changes include additional equity, portfolio cleanup, and a new strategic investor. Download the full report at the provided link -
-
-
-
-
-
PRESS RELEASE
Guerbet: Appointment of Mr. François Convenant as Senior Vice President of Interventional Radiology and his entry into the Executive Committee
Guerbet appoints François Convenant as Senior Vice President of Interventional Radiology, joining the Executive Committee. Reinforcing leadership in interventional radiology -
-